comparemela.com

Cell Projects Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Saliva-based Screening Market to prove to be the digitized mouthpiece at a CAGR of 8%

The global saliva-based screening market was valued at US$ 277 Mn in 2020, and is expected to exhibit a CAGR of 8% over the forecast period 2021-2031.

New yorkUnited statesZymo research corporationOrasure technologiesNeumodx molecular incGenotek incPersistence market researchBiochain institute incCompany profilesSpectrum solutionsMolecular diagnostic testing spectrum solutionsChembio diagnostics incXiamen zeesan biotech co ltdKyodo international incCell projects ltdSedia biosciences corporation

The COVID-19 Saliva-based Screening Market to sizzle at a CAGR of -3% between 2022-2031

The global COVID-19 saliva-based screening market was valued at over US$ 1.7 Bn in 2020, and is expected to exhibit a declining CAGR of -3% between 2022-2031.

New yorkUnited statesZymo research corporationTherma bright incArcis biotechnologyThermo fisherPersistence market researchKolplast groupTakara bio incChembio diagnostics incCell projects ltdVatic healthMiraclean technology coNeumodx molecular incHangzhou co ltdHotgen biotech co ltd

COVID-19 Saliva-based Screening Market is likely to register double digit 2 4% CAGR during 2026

COVID-19 Saliva-based Screening Market is likely to register double digit 2.4% CAGR during 2026 – 2031

United statesZymo research corporationTherma bright incArcis biotechnologyThermo fisherPersistence market researchKolplast groupResearch newswireTakara bio incChembio diagnostics incCell projects ltdVatic healthMiraclean technology coNeumodx molecular incHangzhou co ltdHotgen biotech co ltd

vimarsana © 2020. All Rights Reserved.